These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 17257515

  • 1. Medications in the treatment of borderline personality disorder 2006.
    Mercer D.
    Curr Psychiatry Rep; 2007 Feb; 9(1):53-62. PubMed ID: 17257515
    [Abstract] [Full Text] [Related]

  • 2. Psychopharmacological treatment in borderline personality disorder.
    Díaz-Marsá M, González Bardanca S, Tajima K, García-Albea J, Navas M, Carrasco JL.
    Actas Esp Psiquiatr; 2008 Feb; 36(1):39-49. PubMed ID: 18286399
    [Abstract] [Full Text] [Related]

  • 3. [Update on Current Care Guideline: Borderline personality disorder].
    Korkeila J, Kantojärvi L, Koivisto M, Karlsson H, Keinänen M, Lindeman S, Nikkilä H, Stenberg JH, Taiminen T, Jousilahti P, Tuunainen A.
    Duodecim; 2015 Feb; 131(16):1484-5. PubMed ID: 26485941
    [Abstract] [Full Text] [Related]

  • 4. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms.
    Mercer D, Douglass AB, Links PS.
    J Pers Disord; 2009 Apr; 23(2):156-74. PubMed ID: 19379093
    [Abstract] [Full Text] [Related]

  • 5. Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics?
    Abraham PF, Calabrese JR.
    J Affect Disord; 2008 Nov; 111(1):21-30. PubMed ID: 18304647
    [Abstract] [Full Text] [Related]

  • 6. Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association.
    American Psychiatric Association Practice Guidelines.
    Am J Psychiatry; 2001 Oct; 158(10 Suppl):1-52. PubMed ID: 11665545
    [No Abstract] [Full Text] [Related]

  • 7. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder.
    Zanarini MC, Frankenburg FR, Parachini EA.
    J Clin Psychiatry; 2004 Jul; 65(7):903-7. PubMed ID: 15291677
    [Abstract] [Full Text] [Related]

  • 8. Managing aggressive behavior in patients with obsessive-compulsive disorder and borderline personality disorder.
    Hollander E.
    J Clin Psychiatry; 1999 Jul; 60 Suppl 15():38-44. PubMed ID: 10418814
    [Abstract] [Full Text] [Related]

  • 9. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials.
    Lieb K, Völlm B, Rücker G, Timmer A, Stoffers JM.
    Br J Psychiatry; 2010 Jan; 196(1):4-12. PubMed ID: 20044651
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of pharmacotherapies for borderline personality disorder.
    Bellino S, Paradiso E, Bogetto F.
    CNS Drugs; 2008 Jan; 22(8):671-92. PubMed ID: 18601305
    [Abstract] [Full Text] [Related]

  • 11. State of the art in the pharmacologic treatment of borderline personality disorder.
    Feurino L, Silk KR.
    Curr Psychiatry Rep; 2011 Feb; 13(1):69-75. PubMed ID: 21140245
    [Abstract] [Full Text] [Related]

  • 12. [Pharmacotherapy effectiveness for some symptoms of borderline personality disorder].
    Benjaminsen S.
    Ugeskr Laeger; 2014 Sep 01; 176(36):. PubMed ID: 25293847
    [Abstract] [Full Text] [Related]

  • 13. Psychopharmacology of borderline personality disorder.
    Raj YP.
    Curr Psychiatry Rep; 2004 Jun 01; 6(3):225-31. PubMed ID: 15142476
    [Abstract] [Full Text] [Related]

  • 14. Pharmacotherapy of borderline personality disorder.
    Hirschfeld RM.
    J Clin Psychiatry; 1997 Jun 01; 58 Suppl 14():48-52; discussion 53. PubMed ID: 9418746
    [Abstract] [Full Text] [Related]

  • 15. Olanzapine plus dialectical behavior therapy for women with high irritability who meet criteria for borderline personality disorder: a double-blind, placebo-controlled pilot study.
    Linehan MM, McDavid JD, Brown MZ, Sayrs JH, Gallop RJ.
    J Clin Psychiatry; 2008 Jun 01; 69(6):999-1005. PubMed ID: 18466045
    [Abstract] [Full Text] [Related]

  • 16. Recent trends in the pharmacotherapy of personality disorders.
    Markovitz PJ.
    J Pers Disord; 2004 Feb 01; 18(1):90-101. PubMed ID: 15061346
    [Abstract] [Full Text] [Related]

  • 17. Treatment of personality disorder.
    Bateman AW, Gunderson J, Mulder R.
    Lancet; 2015 Feb 21; 385(9969):735-43. PubMed ID: 25706219
    [Abstract] [Full Text] [Related]

  • 18. [Pharmacological treatment for patients with borderline personality disorder: practice and study results].
    Schwerthöffer D, Bäuml J, Rentrop M.
    Fortschr Neurol Psychiatr; 2013 Aug 21; 81(8):437-43. PubMed ID: 23939557
    [Abstract] [Full Text] [Related]

  • 19. Antipsychotics, antidepressants, anticonvulsants, and placebo on the symptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials.
    Vita A, De Peri L, Sacchetti E.
    J Clin Psychopharmacol; 2011 Oct 21; 31(5):613-24. PubMed ID: 21869691
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological treatments for personality disorders.
    Paris J.
    Int Rev Psychiatry; 2011 Jun 21; 23(3):303-9. PubMed ID: 21923229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.